Form 4: USANA Director Peggie Pelosi Converts RSUs, Increases Common Stock Holdings

Sentiment:

Insider Transaction Report


USANA Health Sciences Director Peggie Pelosi converted restricted stock units into common shares and sold a portion for tax withholding, resulting in a net increase in her direct share ownership.

Summary

  • Director Peggie Pelosi of USANA Health Sciences Inc. reported transactions related to her equity holdings.
  • On July 24, 2025, 1,058 Restricted Stock Units (RSUs) were converted into 1,058 shares of USNA common stock.
  • Concurrently, 606 shares of common stock were disposed of at a price of $32.09 per share, likely to cover tax obligations related to the RSU vesting.
  • Following these transactions, Ms. Pelosi directly holds 4,135 shares of common stock and 3,172 Restricted Stock Units.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as a director increased their net direct shareholding through RSU vesting, indicating continued alignment with shareholder interests, despite a portion being sold for tax purposes which is a neutral event.

Positives

  • Director Peggie Pelosi increased her direct beneficial ownership of common stock by 452 shares (1,058 acquired minus 606 disposed for tax).
  • The conversion of Restricted Stock Units into common stock indicates the vesting of previously granted equity awards, aligning director incentives with shareholder interests.

Negatives

  • A portion of the acquired shares (606 shares) was sold to cover tax liabilities, which is a common practice but represents a reduction in direct shareholding from the gross amount vested.

Future Outlook

Remaining Restricted Stock Units (3,172) are scheduled to vest in three additional 25% tranches on October 23, 2025, January 22, 2026, and April 23, 2026.

Industry Context

This transaction is a routine insider filing, common for directors receiving equity compensation. It reflects the standard practice of RSU vesting and subsequent share sales for tax purposes, which is typical across various industries for executive and director compensation.

Comparison to Industry Standards

  • The RSU vesting and subsequent sale for tax withholding are standard practices for equity compensation in publicly traded companies across various sectors, including the health sciences and direct selling industries.
  • This type of transaction is not typically compared to specific company or project results but rather to general corporate governance and compensation norms.
  • Companies like Herbalife Nutrition Ltd. (HLF) or Nu Skin Enterprises, Inc. (NUS), which operate in similar direct selling or health and wellness sectors, often utilize similar equity compensation structures for their directors and executives, leading to comparable Form 4 filings for RSU vesting and tax-related sales.

Related Party Transactions

  • The reported transactions involve a director of the company, Peggie Pelosi, exercising and selling company securities, which constitutes a related party transaction under SEC rules.

Stakeholder Impact

  • Shareholders: The net increase in a director's direct shareholding, even if small, can be viewed positively as it aligns the director's interests with those of shareholders. The sale for tax purposes is a neutral event.
  • Employees: No direct impact on employees is indicated by this filing.
  • Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Next Steps

  • Remaining 3,172 Restricted Stock Units will vest in 25% increments on October 23, 2025, January 22, 2026, and April 23, 2026.

Key Dates

DateDescription
07/24/2025Date of earliest transaction, involving the conversion of Restricted Stock Units (RSUs) into common stock and the disposition of shares for tax withholding.
07/24/2025First vesting date for 25% of the remaining Restricted Stock Units.
07/28/2025Signature date of the filing by Joshua Foukas, Attorney-in-Fact for Peggie Pelosi.
10/23/2025Second vesting date for 25% of the remaining Restricted Stock Units.
01/22/2026Third vesting date for 25% of the remaining Restricted Stock Units.
04/23/2026Fourth and final vesting date for 25% of the remaining Restricted Stock Units.

Recommendation

hold

This Form 4 filing details a routine insider transaction involving the vesting of Restricted Stock Units and a subsequent sale for tax purposes, resulting in a net increase in the director's direct shareholding. Such transactions are common and generally do not indicate a significant change in the company's fundamental outlook or warrant a change in investment recommendation. The transaction aligns the director's interests with shareholders but does not provide new information to justify a 'buy' or 'sell' recommendation.

Keywords

USANA Health Sciences, USNA, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Director Stock Ownership, Equity Compensation, Shareholding, Peggie Pelosi

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.